Episode 041: J.D. Mowery, President and CEO of KBI Biopharma, discusses his career journey and the role of CDMOs in the biotech and pharma industry. He emphasizes the importance of relationships, risk-taking, and continuous learning in his career success.
J.D. highlights the unique combination of expertise required to work in both biotech and CDMO companies. He explains the challenges faced by biotech and pharma companies that have led to the rise of CDMOs.
Harsh asks J.D. to share the key factors to consider when selecting a CDMO. They introduce the concept of a next-generation CDMO, focusing on regulatory leadership, R&D and innovation, and risk sharing.
The 3 Most Important Pillars of a Next-Generation CDMO, Explained!
-----
Links:
*J.D. Mowery LinkedIn ( / jdmowery )
*KBI Biopharma (www.kbibiopharma.com/)
*Harsh Thakkar LinkedIn ( / harshvthakkar )
*Listen to this episode on the go!
🍎Apple podcast: apple.co/3RXPoS1
🟩 Spotify podcast: spoti.fi/3EbDZbr
👍 Like this video if you're inspired by the innovative approaches CDMOs like KBI Biopharma are bringing to biotech.
💬 Comment below with your thoughts on the role of CDMOs in advancing patient care through biopharmaceuticals.
🔔 Subscribe to our channel @lifesciences360 for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.
-----
Show Notes:
(0:00) Intro to J.D. Mowery &KBI Biopharma
(3:49) J.D.'s Journey from Biotech to CDMO
(7:17) Biopharma Challenges driving the CDMO trend
(11:47) What to Look for in a CDMO
(14:18) The 3 MOST important pillars of next-gen CDMO
(22:05) Team Leadership & Culture at KBI
(25:28) What J.D. looks for in a New Team Member
(30:32) Most Rewarding Aspect of Working in Life Sciences
(32:21) Stay in Touch with J.D.
#cdmo #biopharma #kbibiopharma #regulatorypartnerships #biotechmanufacturing #pharmaceuticaloutsourcing #patientcare
#biotech #biotechinnovation #relationships #researchanddevelopment #collaboration #LifeSciences360 #cdmoinsights #biopharmapartnerships #contractmanufacturing #pharmaoutsourcing #regulatorycompliance #randdinnovation #riskmanagement #nextgencdmo #drugdevelopment #biotechcollaboration